Zai Lab Ltd

Healthcare · Biotechnology

24.80$ -2.0% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Zai Lab Ltd (ZLAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,075 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ZLAB
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	89	89	104	104	250	250	250	211	302	302	446	446	392	355	355	548	548	1,298	1,131	1,895	1,728	1,610	1,501	1,419	1,299	1,220	1,170	1,106	1,044	1,036	988	987	985	1,186	1,173	1,164	1,159	1,172	1,096	1,075
Current Assets	84	84	94	94	231	231	231	182	269	269	402	402	329	292	276	485	1,216	1,216	1,049	1,809	1,619	1,501	1,393	1,336	1,210	1,124	1,072	1,018	960	940	889	870	861	1,050	1,042	1,034	1,033	1,019	945	914
Cash	84	84	93	93	230	230	230	128	63	63	92	92	69	76	-276	259	–	442	1,013	1,767	1,398	964	847	681	1,119	1,008	880	859	789	790	651	630	616	450	757	732	717	680	651	608
Cash & Short-Term Investments	84	84	93	93	230	230	230	178	–	263	393	393	320	276	276	464	–	1,187	1,013	1,767	1,568	1,409	1,312	1,256	1,119	1,008	930	875	820	806	651	630	616	780	757	732	717	690	661	618
Receivables	–	–	–	–	–	–	–	–	0.1	0.1	2.5	2.5	3.9	3.8	3.8	7.0	5.2	5.2	8.8	18	21	55	44	38	39	49	61	68	65	65	76	78	69	89	88	99	105	106	54	73
Inventory	–	–	–	–	–	–	–	–	0.0	0.0	0.1	0.1	0.9	6.0	6.0	6.6	13	13	13	11	12	19	20	23	29	32	38	36	44	45	38	42	40	40	53	62	67	75	86	91
Property, Plant & Equipment	1.2	1.2	7.0	7.0	12	12	19	19	20	20	30	30	35	36	35	35	47	47	46	49	53	57	62	65	71	77	–	75	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	-7.7	-7.7	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	0.3	0.3	0.7	0.7	8.6	8.8	8.8	8.6	–	9.4	9.4	9.6	9.4	9.7	9.5	9.0	8.4	8.4	8.4	4.8	4.6	16	15	47	55	59	59	57	58	76	76	86
Total Liabilities	5.2	140	9.6	175	12	14	14	12	51	51	53	53	55	60	60	83	–	128	122	224	140	230	193	207	193	175	169	174	163	240	226	283	318	345	363	372	399	457	434	468
Current Liabilities	5.2	5.2	9.6	9.6	12	12	12	10	49	49	46	46	41	47	47	57	98	98	93	194	112	193	155	169	156	140	125	133	125	203	192	252	286	299	320	332	360	416	393	429
Short-Term Debt	–	–	–	–	–	2,394	2,394	0.8	–	3.6	8.7	8.7	10	11	11	8.4	–	5.2	5.6	6.4	6.3	5.9	6.8	6.8	7.0	7.1	7.3	7.3	6.9	7.1	56	78	120	140	180	180	209	211	220	243
Accounts Payable	0.5	0.5	4.0	4.0	9.0	9.0	9.0	5.7	37	37	28	28	20	23	23	32	63	63	41	126	51	126	98	108	90	66	66	67	55	113	88	127	121	101	103	107	100	142	126	137
Shareholders' Equity	83	-52	93	-71	235	235	235	199	251	251	393	393	337	295	295	465	–	1,169	1,010	1,672	1,588	1,380	1,308	1,212	1,106	1,046	1,001	932	881	796	762	704	668	841	811	792	760	716	662	607
Retained Earnings	-60	-60	-85	-85	-111	-111	-111	–	-250	-250	-250	–	-398	-445	-445	-573	-714	-714	-947	-1,110	-1,206	-1,418	-1,500	-1,638	-1,800	-1,861	-1,911	-2,031	-2,101	-2,196	-2,249	-2,330	-2,371	-2,453	-2,502	-2,542	-2,578	-2,629	-2,680	-2,730
Shares Outstanding	96	96	106	106	329	3,288	3,288	500	523	580	609	609	677	679	730	747	754	875	884	930	950	954	955	958	959	960	961	965	969	970	973	976	976	102	108	109	110	111	111	112

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings